TokenPost topic

AI drug development

1 TokenPost story is tagged AI drug development. The newest appear first.

Latest AI drug development stories

• Nvidia-Backed Iambic Therapeutics Prices IPO at $16 a Share

  The AI drug developer is offering about 9.38 million shares and expects to begin trading on Nasdaq on Oct. 15 under ticker IAM.

  Oct 14, 2026, 8:42 PM EDT · Business